Colorectal Cancer Clinical Trial
| NCT number | NCT00034619 |
| Other study ID # | 5142 |
| Secondary ID | H3E-MC-JMEP |
| Status | Completed |
| Phase | Phase 2 |
| First received | May 1, 2002 |
| Last updated | July 18, 2006 |
| Verified date | July 2006 |
| Source | Eli Lilly and Company |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | United States: Food and Drug Administration |
| Study type | Interventional |
The purpose of this study is to assess the antitumor activity of ALIMTA plus Oxaliplatin combination therapy in patients with previously untreated advanced colorectal cancer
| Status | Completed |
| Enrollment | 0 |
| Est. completion date | |
| Est. primary completion date | |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - Diagnosis of primary cancer of the colon or rectum - Must have measurable disease - Must be able to comply with study procedure Exclusion Criteria: - Prior chemotherapy for advanced disease - Pregnancy or lactation - Candidates for surgical resection of one or more metastatic foci - Second primary cancer - Inability to take folic acid or vitamin B12 |
Primary Purpose: Treatment
| Country | Name | City | State |
|---|---|---|---|
| United States | "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" | Asheville | North Carolina |
| United States | "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" | Bellevue | Washington |
| United States | "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" | Bend | Oregon |
| United States | "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" | Charleston | South Carolina |
| United States | "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" | Columbus | Ohio |
| United States | "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" | Goldsboro | North Carolina |
| United States | "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" | Hendersonville | North Carolina |
| United States | "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" | Huntsville | Alabama |
| United States | "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" | Ivins | Utah |
| United States | "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" | Kalamazoo | Michigan |
| United States | "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" | Latham | New York |
| United States | "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" | Ogden | Utah |
| United States | "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" | Philadelphia | Pennsylvania |
| United States | "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" | Pittsburgh | Pennsylvania |
| United States | "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" | Pittsfield | Massachusetts |
| United States | "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" | Portland | Oregon |
| United States | "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" | Provo | Utah |
| United States | "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" | Reading | Pennsylvania |
| United States | "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" | Seattle | Washington |
| United States | "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" | Spokane | Washington |
| United States | "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" | St. George | Utah |
| United States | "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" | Winston-Salem | North Carolina |
| Lead Sponsor | Collaborator |
|---|---|
| Eli Lilly and Company |
United States,
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05400122 -
Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer
|
Phase 1 | |
| Active, not recruiting |
NCT05551052 -
CRC Detection Reliable Assessment With Blood
|
||
| Completed |
NCT00098787 -
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
|
Phase 2 | |
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT05425940 -
Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer
|
Phase 3 | |
| Suspended |
NCT04595604 -
Long Term Effect of Trimodal Prehabilitation Compared to ERAS in Colorectal Cancer Surgery.
|
N/A | |
| Completed |
NCT03414125 -
Effect of Mailed Invites of Choice of Colonoscopy or FIT vs. Mailed FIT Alone on Colorectal Cancer Screening
|
N/A | |
| Completed |
NCT02963831 -
A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05489211 -
Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
|
Phase 2 | |
| Terminated |
NCT01847599 -
Educational Intervention to Adherence of Patients Treated by Capecitabine +/- Lapatinib
|
N/A | |
| Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
| Recruiting |
NCT03874026 -
Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer Patients
|
Phase 2 | |
| Active, not recruiting |
NCT03170960 -
Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
|
Phase 1/Phase 2 | |
| Completed |
NCT03167125 -
Participatory Research to Advance Colon Cancer Prevention
|
N/A | |
| Completed |
NCT03181334 -
The C-SPAN Coalition: Colorectal Cancer Screening and Patient Navigation
|
N/A | |
| Recruiting |
NCT04258137 -
Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study
|
N/A | |
| Recruiting |
NCT05568420 -
A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC)
|
||
| Recruiting |
NCT02972541 -
Neoadjuvant Chemotherapy Verse Surgery Alone After Stent Placement for Obstructive Colonic Cancer
|
N/A | |
| Completed |
NCT02876224 -
Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors
|
Phase 1 | |
| Completed |
NCT01943500 -
Collection of Blood Specimens for Circulating Tumor Cell Analysis
|
N/A |